FENNEC PHARMACEUTICALS INC.

FENC Nasdaq CIK: 0001211583

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation British Columbia, Canada
Business Address PO BOX 13628, RESEARCH TRIANGLE PARK, NC, 27709
Mailing Address PO BOX 13628, RESEARCH TRIANGLE PARK, NC, 27709
Phone (919) 636-4530
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2024 FY

$47.54M
Revenue
-$436K
Net Income

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 11, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report January 23, 2026 View on SEC
4 Insider stock transaction report January 15, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 14, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC

Insider Trading

STRONG SELL 2 insiders 5 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.